Balaxi Pharmaceuticals Ltd
BALAXIBalaxi Pharmaceuticals Ltd
BALAXI
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹422 cr, stock is ranked 1,644
High RiskStock is 3.88x as volatile as Nifty
418.451.30% (+5.35)
418.451.30% (+5.35)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -39.87 | 2.31 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.51 | 5.11 | 0.71% |
Forecast & Ratings
Detailed Forecast—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
The company is engaged in wholesale trading of pharmaceuticals products, food products and builders’ hardware products. The Company offers a range of food and biscuit products under the brand name YAP.
Investor Presentation
View olderPeers
Compare with peersPoly Medicure Ltd
PE Ratio
85.25
1Y Return
68.89%
Buy Reco %
80.00
Tarsons Products Ltd
PE Ratio
31.10
1Y Return
35.96%
Buy Reco %
100.00
Universus Photo Imagings Ltd
PE Ratio
-9.83
1Y Return
24.93%
Buy Reco %
—
Mohini Health & Hygiene Ltd
PE Ratio
19.67
1Y Return
26.66%
Buy Reco %
—
Shree Pacetronix Ltd
PE Ratio
30.37
1Y Return
124.93%
Buy Reco %
—
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.24 | 0.05 | 0.00 | 0.00 | 14.49 | 46.22 | 233.56 | 284.36 | 339.07 | 288.08 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 32.83 | 172.15 | 195.60 | 202.42 | 286.97 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 0.28 | |||||||||||
| Employee Cost | 0.02 | 0.06 | 0.07 | 0.15 | 0.90 | 2.10 | 8.47 | 12.47 | 28.95 | |||||||||||
| Selling & Administrative Expenses | 0.04 | 0.05 | 0.07 | 0.61 | 0.59 | 1.75 | 4.74 | 17.56 | 42.29 | |||||||||||
| Operating & Other expenses | 0.02 | 0.01 | -0.01 | 0.01 | 10.55 | 0.70 | 3.30 | 2.59 | 5.08 | |||||||||||
EBITDA | 0.16 | -0.07 | -0.13 | -0.77 | 2.45 | 8.84 | 44.90 | 55.79 | 60.05 | 1.11 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.30 | 0.51 | 1.75 | 2.33 | ||||||||||
| PBIT | 0.16 | -0.07 | -0.13 | -0.77 | 2.45 | 8.83 | 44.60 | 55.28 | 58.30 | -1.22 | ||||||||||
| Interest & Other Items | 0.01 | 0.05 | 0.04 | 0.00 | 0.00 | 0.05 | 0.28 | 0.76 | 1.38 | 0.94 | ||||||||||
| PBT | 0.15 | -0.12 | -0.17 | -0.77 | 2.45 | 8.78 | 44.32 | 54.52 | 56.92 | -2.16 | ||||||||||
| Taxes & Other Items | 0.04 | -0.04 | 0.00 | 0.00 | 0.47 | 2.69 | 6.19 | 6.86 | 10.96 | 8.44 | ||||||||||
| Net Income | 0.11 | -0.08 | -0.17 | -0.77 | 1.98 | 6.09 | 38.13 | 47.66 | 45.96 | -10.60 | ||||||||||
| EPS | 0.59 | -0.26 | -0.56 | -2.53 | 6.51 | 9.34 | 38.13 | 47.66 | 45.55 | -10.41 | ||||||||||
| DPS | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
Company Updates
FY 2022
Investor Presentation
Jun 24PDF
Feb 15PDF
Nov 2PDF
Jul 19PDF
FY 2023
Investor Presentation
May 29PDF
Feb 1PDF
Nov 5PDF
+2 more
FY 2024
Investor Presentation
Aug 3PDF
Peers & Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Balaxi Pharmaceuticals Ltd | 9.20 | 2.31 | — |
| Poly Medicure Ltd | 85.25 | 12.31 | 0.19% |
| Tarsons Products Ltd | 31.10 | 4.41 | — |
| Universus Photo Imagings Ltd | -9.83 | 0.42 | 2.51% |
Price Comparison
Compare BALAXI with any stock or ETFCompare BALAXI with any stock or ETF
BALAXI
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 1, 2022
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Jul 1, 2022
News & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant